• Mithra appoints experienced life sciences executive Christian Homsy* as Chairman

    1 day ago

  • Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Friday May 26th 2023

  • How garbage disposal clogs in cells can lead to Alzheimer’s

    Friday May 26th 2023

  • The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services

    Thursday May 25th 2023

  • GEVERS, the torch is passed

    Thursday May 25th 2023

  • The QbD Group acquires Michor Consulting to enhance its regulatory affairs services across Europe

    Thursday May 25th 2023

  • Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis

    Wednesday May 24th 2023

  • Scientists shed light on a sleep peptide involved in Alzheimer’s

    Wednesday May 17th 2023

  • Your news here?

  • Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

    Monday May 15th 2023

  • Researchers reveal a crucial process in the working of the immune system

    Monday May 15th 2023

  • Mithra announces completion of recruitment in pediatric study of Estelle in adolescent patients

    Thursday May 11th 2023

Strategic Partners